PubMed

Clinical relevance of neutral endopeptidase (NEP/CD10) in melanoma.

Velazquez EF, Yancovitz M, Pavlick A, Berman R, Shapiro R, Bogunovic D, O'Neill D, Yu YL, Spira J, Christos PJ, Zhou XK, Mazumdar M, Nanus DM, Liebes L, Bhardwaj N, Polsky D, Osman I.

J Transl Med. 2007 Jan 5;5:2.PMID: 17207277 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression of neutral endopeptidase (NEP/CD10) on pancreatic tumor cell lines, pancreatitis and pancreatic tumor tissues.

Erhuma M, Köbel M, Mustafa T, Wulfänger J, Dralle H, Hoang-Vu C, Langner J, Seliger B, Kehlen A.

Int J Cancer. 2007 Jun 1;120(11):2393-400.PMID: 17294442 [PubMed - indexed for MEDLINE]Related articles

Gene expression profiling of human melanoma cell lines with distinct metastatic potential identifies new progression markers.

Bertucci F, Pages C, Finetti P, Rochaix P, Lamant L, Devilard E, Nguyen C, Houlgatte R, Birnbaum D, Xerri L, Brousset P.

Anticancer Res. 2007 Sep-Oct;27(5A):3441-9.PMID: 17970093 [PubMed - indexed for MEDLINE]Related articles

Loss of neutral endopeptidase and activation of protein kinase B (Akt) is associated with prostate cancer progression.

Osman I, Dai J, Mikhail M, Navarro D, Taneja SS, Lee P, Christos P, Shen R, Nanus DM.

Cancer. 2006 Dec 1;107(11):2628-36.PMID: 17083125 [PubMed - indexed for MEDLINE]Related articlesFree article

Receptor-mediated down-regulation of neutral endopeptidase (NEP; EC 3.4.24.11; CD10) on immature B lymphocytes by dexamethasone.

Cupic B, Breljak D, Gabrilovac J.

Int J Mol Med. 2005 Jun;15(6):1023-31.PMID: 15870909 [PubMed - indexed for MEDLINE]Related articles

Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: a result of transformation or differentiation?

Gilhooly EM, Morse-Gaudio M, Bianchi L, Reinhart L, Rose DP, Connolly JM, Reed JA, Albino AP.

Melanoma Res. 2001 Aug;11(4):355-69.PMID: 11479424 [PubMed - indexed for MEDLINE]Related articles

Differential expression of neutral endopeptidase-24.11 (neprilysin) and endothelin-converting enzyme in human prostate cancer cell lines.

Usmani BA, Harden B, Maitland NJ, Turner AJ.

Clin Sci (Lond). 2002 Aug;103 Suppl 48:314S-317S.PMID: 12193112 [PubMed - indexed for MEDLINE]Related articles

Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.

Kitago M, Martinez SR, Nakamura T, Sim MS, Hoon DS.

Clin Cancer Res. 2009 May 1;15(9):2988-94. Epub 2009 Mar 31.PMID: 19336521 [PubMed - indexed for MEDLINE]Related articles

The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells.

Slipicevic A, Jørgensen K, Skrede M, Rosnes AK, Trøen G, Davidson B, Flørenes VA.

BMC Cancer. 2008 Sep 30;8:276.PMID: 18826602 [PubMed - indexed for MEDLINE]Related articlesFree article

CD10/neutral endopeptidase 24.11 in developing human fetal lung. Patterns of expression and modulation of peptide-mediated proliferation.

Sunday ME, Hua J, Torday JS, Reyes B, Shipp MA.

J Clin Invest. 1992 Dec;90(6):2517-25.PMID: 1469102 [PubMed - indexed for MEDLINE]Related articlesFree article

Phorbol ester-mediated regulation of CD10/neutral endopeptidase transcripts in acute lymphoblastic leukemias.

Ishimaru F, Potter NS, Shipp MA.

Exp Hematol. 1996 Jan;24(1):43-8.PMID: 8536791 [PubMed - indexed for MEDLINE]Related articles

Neutral endopeptidase 24.11/CD10 suppresses progressive potential in ovarian carcinoma in vitro and in vivo.

Kajiyama H, Shibata K, Terauchi M, Morita T, Ino K, Mizutani S, Kikkawa F.

Clin Cancer Res. 2005 Mar 1;11(5):1798-808.PMID: 15756002 [PubMed - indexed for MEDLINE]Related articlesFree article

Neutral endopeptidase protein expression and prognosis in localized prostate cancer.

Osman I, Yee H, Taneja SS, Levinson B, Zeleniuch-Jacquotte A, Chang C, Nobert C, Nanus DM.

Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4096-100.PMID: 15217945 [PubMed - indexed for MEDLINE]Related articlesFree article

Increased expression of neprilysin (neutral endopeptidase 24.11) in rat and human hepatocellular carcinomas.

Dragović T, Deddish PA, Tan F, Weber G, Erdös EG.

Lab Invest. 1994 Jan;70(1):107-13.PMID: 8302012 [PubMed - indexed for MEDLINE]Related articles

The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis.

Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C, Xi Y, Howell P, Metge B, Samant RS, Shevde LA, Li W, Eschrich S, Daud A, Ju J, Matta J.

BMC Med Genomics. 2008 Apr 28;1:13.PMID: 18442402 [PubMed]Related articlesFree article

Loss of expression of receptor tyrosine kinase family genes PTK7 and SEK in metastatic melanoma.

Easty DJ, Mitchell PJ, Patel K, Flørenes VA, Spritz RA, Bennett DC.

Int J Cancer. 1997 Jun 11;71(6):1061-5.PMID: 9185712 [PubMed - indexed for MEDLINE]Related articles

The expression and localization of neutral endopeptidase 24.11/CD10 in human gestational trophoblastic diseases.

Ino K, Suzuki T, Uehara C, Nagasaka T, Okamoto T, Kikkawa F, Mizutani S.

Lab Invest. 2000 Nov;80(11):1729-38.PMID: 11092533 [PubMed - indexed for MEDLINE]Related articles

Down-regulation of pro-apoptotic genes is an early event in the progression of malignant melanoma.

Jensen EH, Lewis JM, McLoughlin JM, Alvarado MD, Daud A, Messina J, Enkemann S, Yeatman TJ, Sondak VK, Riker AI.

Ann Surg Oncol. 2007 Apr;14(4):1416-23. Epub 2006 Dec 30.PMID: 17195911 [PubMed - indexed for MEDLINE]Related articles

Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis.

Chetoui N, Sylla K, Gagnon-Houde JV, Alcaide-Loridan C, Charron D, Al-Daccak R, Aoudjit F.

Mol Cancer Res. 2008 Jan;6(1):42-52.PMID: 18234961 [PubMed - indexed for MEDLINE]Related articlesFree article

Association of insulin-like growth factor binding protein-3 expression with melanoma progression.

Xi Y, Nakajima G, Hamil T, Fodstad O, Riker A, Ju J.

Mol Cancer Ther. 2006 Dec;5(12):3078-84.PMID: 17172410 [PubMed - indexed for MEDLINE]Related articlesFree article